ABOUT US

A growing market

  • In 2012 in the US alone, 6 million patients (2% of population) suffered from chronic wounds.
  • Chronic wound care costs exceed $50 billion per year (conservative estimate).
  • In 2012, the global wound care management market stood at $11.7 billion.
  • The projected 2021 worth of the wound care management market is $18.5 billion.
  • Demographic factors such as aging, diabetes, and obesity contribute to rapid market growth.
  • Key drivers include the Affordable Care Act and recent Center for Medicare and Medicaid Services proposals.

Potential customers

  • Trauma physicians, dermatologists, plastic surgeons, and treatment centers.
  • Medical device companies (potential distributors or licensees with established distribution channels)
  • Our wound patients (end users), that suffer from chronic wounds, diabetic foot ulcers, burns, or bedsores
  • Insurance companies as payers in the value chain.

Problem and need

  • The cost of wounds is affected by prolonged and intensified treatment, as well as prolonged hospitalization and specialized treatment.
  • Chronic wounds can lead to serious infections, gangrene, and in the worst cases amputation.
  • Currently low rates of wound closure.
  • Rise in prevalence of chronic wounds, has led to an increased demand for management approaches and device platforms dedicated to wound-care.
  • Actual products continue to provide only palliative treatment: Patient mobility, quality of life and overall individual well being are not positively affected
  • These issues call for a dramatic change of focus on improving the effectiveness of the wound healing process

Value Added

  • We critically examine the total cost of treatment and patient experience over the unit cost for a given product.
  • Reduced wound management time saves significant resources, including hospital bed time, antibiotics, diagnostics, and transfer costs.
  • We create value by enabling healthcare professionals to manage variouse wound etiologies with fewer resources.